Metabolic Syndrome and Risk of Recurrence of Atrial Fibrillation After Catheter Ablation
Metabolic Syndrome and Risk of Recurrence of Atrial Fibrillation After Catheter Ablation
复制标题
代谢综合征和导管消融后心房颤动复发的风险
DOI：
10.1253/circj.cj-08-0832
复制
发表时间：
2009-03-01
影响因子：
3.3
通讯作者：
Ma, Chang-Sheng
中科院分区：
文献类型：
--
作者：
Tang, Ri-Bo;Dong, Jian-Zeng;Ma, Chang-Sheng
背景资料：代谢综合征（MetS），以及心血管疾病的几个危险因素，是已知的与心房颤动（AF），但其对AF导管消融术后复发的影响尚未explored.Methods和结果：654例连续AF患者接受了指数环肺静脉消融术的数据进行了回顾性分析。其中，323例（49.4%）患有MetS，根据修改后的国家胆固醇教育计划-成人治疗M组标准和中国民族标准。平均随访470 323（91- 1，245）天后，MetS患者的AF复发率（43.7%）显著高于非MetS患者（30.5%，P
Background: Metabolic syndrome (MetS), as well as several risk factors of cardiovascular diseases, is known to be associated with atrial fibrillation (AF), but its impact on the recurrence of AF after catheter ablation has not been explored.Methods and Results: The data for 654 consecutive AF patients who underwent an index circumferential pulmonary vein ablation were retrospectively analyzed. Of them, 323 (49.4%) had MetS according to the modified National Cholesterol Education Program-Adult Treatment Panel M criteria and Chinese ethnic criteria. After a mean follow-up of 470 323 (91-1,245) days, patients with MetS had a significantly higher incidence of AF recurrence (43.7%) compared with non-MetS patients (30.5%, P